Patricia L. Stapleton

The Kinetics of Aflatoxin B1Oxidation by Human cDNA-Expressed and Human Liver Microsomal Cytochromes P450 1A2 and 3A4

Evan P. Gallagher, Kent L. Kunze, Patricia L. Stapleton et al. · Toxicology and Applied Pharmacology · 1996 · 265 citations

Pharmacy, Biochemistry, Toxicology +11

Role of human microsomal and human complementary DNA-expressed cytochromes P4501A2 and P4503A4 in the bioactivation of aflatoxin B1.

Evan P. Gallagher, Larry C. Wienkers, Patricia L. Stapleton et al. · PubMed · 1994 · 223 citations

Pharmacy, Biochemistry, Toxicology +17

Association of <b> <i>CYP17, CYP19, CYP1B1</i> </b>, and <b> <i>COMT</i> </b> Polymorphisms with Serum and Urinary Sex Hormone Concentrations in Postmenopausal Women

Shelley S. Tworoger, Jessica Chubak, Erin J. Aiello et al. · Cancer Epidemiology Biomarkers & Prevention · 2004 · 137 citations

Life Sciences, Endocrinology, Genetics +13

Sulforaphane- and Phenethyl Isothiocyanate–Induced Inhibition of Aflatoxin B1–Mediated Genotoxicity in Human Hepatocytes: Role of GSTM1 Genotype and CYP3A4 Gene Expression

Kerstin Groß‐Steinmeyer, Patricia L. Stapleton, Julia Tracy et al. · Toxicological Sciences · 2010 · 86 citations · Full text

Pharmacy, Biochemistry, Toxicology +17

Glutathione S-transferase M1, T1, and P1 polymorphisms and survival among lung cancer patients.

Carol Sweeney, Valle Nazar‐Stewart, Patricia L. Stapleton et al. · PubMed · 2003 · 84 citations

Life Sciences, Genetics, Oncology +15